Adiaspiromycosis Causing Respiratory Failure and a Review of Human Infections Due to Emmonsia and Chrysosporium spp
- 1 April 2012
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (4) , 1346-1354
Abstract
We report a case of a 27-year-old male who presented with respiratory distress that required mechanical ventilation. Transbronchial biopsy revealed adiaspores of the fungus Emmonsia crescens within granulomata, a condition known as adiaspiromycosis. The patient received amphotericin products and corticosteroids, followed by itraconazole, and made a full recovery. Emmonsia crescens is a saprobe with a wide distribution that is primarily a rodent pathogen. The clinical characteristics of the 20 cases of human pulmonary adiaspiromycosis reported since the last comprehensive case review in 1993 are described here, as well as other infections recently reported for the genus Emmonsia . Pulmonary adiaspiromycosis has been reported primarily in persons without underlying host factors and has a mild to severe course. It remains uncertain if the optimal management of severe pulmonary adiaspiromycosis is supportive or if should consist of antifungal treatment, corticosteroids, or a combination of the latter two. The classification of fungi currently in the genus Emmonsia has undergone considerable revision since their original description, including being grouped with the genus Chrysosporium at one time. Molecular genetics has clearly differentiated the genus Emmonsia from the Chrysosporium species. Nevertheless, there has been a persistent confusion in the literature regarding the clinical presentation of infection with fungi of these two genera; to clarify this matter, the reported cases of invasive Chrysosporium infections were reviewed. Invasive Chrysosporium infections typically occur in impaired hosts and can have a fatal course. Based on limited in vitro susceptibility data for Chrysosporium zonatum , amphotericin B is the most active drug, itraconazole susceptibility is strain-dependent, and fluconazole and 5-fluorocytosine are not active.Keywords
This publication has 60 references indexed in Scilit:
- Molecular Diagnosis of Disseminated Adiaspiromycosis Due toEmmonsia crescensJournal of Clinical Microbiology, 2009
- Mycotic Brain Abscess Caused by Opportunistic Reptile PathogenEmerging Infectious Diseases, 2005
- Cutaneous adiaspiromycosis: A distinct dermatologic entity associated with Chrysosporium speciesJournal of the American Academy of Dermatology, 2004
- Pulmonary Colonization by Chrysosporium zonatum Associated with Allergic Inflammation in an Immunocompetent SubjectJournal of Clinical Microbiology, 2002
- Adiaspiromicose pulmonar: achado casual em paciente falecido de febre amarelaRevista da Sociedade Brasileira de Medicina Tropical, 2001
- Adiaspiromicose humana. Relato de um caso tratado com cetoconazolRevista da Sociedade Brasileira de Medicina Tropical, 1997
- Adiaspiromicose pulmonar disseminada. Relato de casoRevista da Sociedade Brasileira de Medicina Tropical, 1997
- Adiaspiromicose pulmonar humana novo caso da forma disseminadaRevista da Sociedade Brasileira de Medicina Tropical, 1990
- Taxonomy of Haplosporangium parvumMycopathologia, 1959
- THE PULMONARY FUNGUS, HAPLOSPORANGIUM PARVUM, AND ITS RELATIONSHIP WITH SOME HUMAN PATHOGENSCanadian Journal of Research, 1947